Ann-Sophie Page

VELPOP 33 Table 2: Subjective outcomes at baseline and after 4 months Laser PFE Mean difference between groups p-value POPDI-6 score N=23 N=23 Baseline 23.91 ± 14.61 26.09 ± 13.66 4 months 19.20 ± 12.55 18.12 ± 11.35 Mean difference versus baseline -4.710 (-11.04;1.616) -7.971 (-14.30;1.644) 3.261 (-5.686;12.208) 0.466 UDI-6 score N=23 N=23 Baseline 23.91 ± 14.55 27.36 ± 20.37 4 months 19.93 ± 15.59 22.46 ± 15.93 Mean difference versus baseline -3.986 (-13.28;5.31) -4.891 (-14.19;4.41) 0.91 (-12.24;14.05) 0.890 PISQ-IR score (sexually active patients) N=13 N=18 Baseline 3.35 ± 0.60 3.44 ± 0.41 4 months 3.63 ± 0.41 3.47 ± 0.43 Mean difference versus baseline 0.22 (0.01;0.44) -0.01 (-0.19;0.17) 0.23 (-0.05;0.52) 0.102 A statistical comparison between both treatment groups was performed on the change scores using a linear model. Results are presented by mean differences with 95% confidence intervals. Table 3: POP-stages at baseline and after 4 months. Laser (n=23) PFE (n=23) Baseline 4 months Baseline 4 months Mean difference (95% CI) p-value Anterior wall prolapse Stage 0 1/23 (4.3%) 2/23 (8.7%) 2/23 (8.7%) 1/22 (4.5%) Stage 1 1/23 (4.3%) 0/23 (0%) 1/23 (4.3%) 0/23 (0%) Stage 2 12/23 (52.2%) 13/23 (56%) 15/23 (65%) 17/22 (77.3%) Stage 3 9/23 (39.1%) 8/23 (34.8%) 5/23 (21.7%) 4/22 (18.2%) Mean change versus baseline (95% CI) -0.087 (-0.277;0.103) 0.045 (-0.149;0.240) -0.132 (-0.404;0.139) 0.331 Cervix / Vault prolapse Stage 0 5/23 (21.7%) 6/23 (26.1%) 5/23 (21.7%) 8/22 (36.4%) Stage 1 14/23 (60.9%) 13/23 (56%) 16/23 (69%) 11/22 (50%) Stage 2 4/23 (17.4%) 4/23 (17.4%) 2/23 (8.7%) 3/22 (13.6%) Stage 3 0/23 (0%) 0/23 (0%) 0/23 (0%) 0/23 (0%) Mean change versus baseline (95% CI) -0.043 (-0.321;0.234) -0.091 (-0.375;0.193) 0.047 (-0.350;0.445) 0.811 Posterior wall prolapse Stage 0 12/23 (52.2%) 12/23 (52%) 6/23 (26.1%) 7/22 (31.8%) Stage 1 8/23 (34.8%) 7/23 (30.4%) 9/23 (39.1%) 9/22 (40.9%) Stage 2 3/23 (13.1%) 4/23 (17.4%) 8/23 (34.8%) 6/22 (27.3%) Stage 3 0/23 (0%) 0/23 (0%) 0/23 (0%) 0/23 (0%) Mean change versus baseline (95% CI) 0.043 (-0.140;0.227) -0.182 (-0.370;0.006) 0.225 (-0.038;0.488) 0.091 A statistical comparison between both treatment groups was performed on the change scores using a linear model. Results are presented by mean differences with 95% confidence intervals.

RkJQdWJsaXNoZXIy MTk4NDMw